Trial intelligence / Profile preview

Alendronate for Vascular Calcification and Arterial Stiffness in CKD

NCT00395382Phase 4Completed

Sponsor
Monash University
Start
Jan 2007
Primary completion
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Vascular calcification and arteriosclerosis comparing Alendronate Arm with Placebo Arm (2 arms). Primary endpoints: Pulse Wave Velocity at 18 months and Vascular Calcification on CT at 18 months. Started Jan 2007; status: completed.

02

Drugs

alendronate
03

Conditions

Vascular calcificationarteriosclerosis

Beyond the preview

Go deeper on NCT00395382.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00395382.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call